We are live on ! Find out more
CNSY

Cerenome
CNSY

14 hedge funds and large institutions have $4.11M invested in Cerenome in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

474% more capital invested

Capital invested by funds: $717K → $4.11M (+$3.4M)

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

75% more funds holding

Funds holding: 8 → 14 (+6)

7.04% more ownership

Funds ownership: 6.26% → 13.3% (+7%)

Holders
14
Holders Change
+6
Holders Change %
+75%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
4
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.53M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$315K
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$276K
4
Two Sigma Investments
Two Sigma Investments
New York
+$261K
5
VF
Virtu Financial
New York
+$183K

Top Sellers

Rank Fund Capital Flow
1
BRWM
B. Riley Wealth Management
Tennessee
-$29K
2
TRCT
Tower Research Capital (TRC)
New York
-$5K
3
Bank of America
Bank of America
North Carolina
-$3.61K

CNSY Hedge Fund Activity: Q2 2021 in Review

14 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Cerenome (CNSY) for Q2 2021, worth a combined $4.11M — up 474% from $717K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CNSY positions and 3 closed out — a net gain of 6 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.53M. The largest seller was B. Riley Wealth Management, exiting entirely with an estimated $29K sold.

  • 14 institutional investors held Cerenome (CNSY) as of Q2 2021, up from 8 in Q1 2021.
  • Funds reported $4.11M of Cerenome stock for Q2 2021, up 474% quarter-over-quarter.
  • 9 funds opened new Cerenome positions in Q2 2021 and 3 closed out, a net change of +6 holders.
  • The largest Cerenome buyer in Q2 2021 was Vanguard Group, an estimated $1.53M added.
  • The largest Cerenome seller in Q2 2021 was B. Riley Wealth Management, an estimated $29K sold.

Based on aggregated 13F filings for Q2 2021.